The California-based firm said that its VeriClear EbV MARV Rapid Antigen Test will be used for the detection and differentiation of Ebola and Marburg virus infections.

Last week, readers were most interested in a story about alternatives to blood as sample types for diagnostic testing.

NEW YORK – As the federal government shutdown stretches into its third week, stakeholders in the clinical laboratory and diagnostics spaces are assessing its impact on those industries. While perhaps ...

The University of Washington spinout's test is used to detect and analyze protein biomarkers in a low-cost test, with results in 15 minutes.

The firms intend to comarket genomic solutions combining clinical decision support and genomic workflow integration with microarray testing.